Clinical Trial Update: SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether an SGLT2 inhibitor can reduce postoperative atrial fibrillation in patients with chronic coronary syndrome awaiting corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Region Örebro County | Conditions: Chronic Coronary Syndrome, Atrial Fibrillation | Phase 3 | Status: RECRUITING